Do 18F-FDG PET/CT Parameters in Oropharyngeal and Oral Cavity Squamous Cell Carcinomas Indicate HPV Status?. (March 2015)
- Record Type:
- Journal Article
- Title:
- Do 18F-FDG PET/CT Parameters in Oropharyngeal and Oral Cavity Squamous Cell Carcinomas Indicate HPV Status?. (March 2015)
- Main Title:
- Do 18F-FDG PET/CT Parameters in Oropharyngeal and Oral Cavity Squamous Cell Carcinomas Indicate HPV Status?
- Authors:
- Kendi, Ayse Tuba Karagulle
Magliocca, Kelly
Corey, Amanda
Nickleach, Dana C.
Galt, James
Higgins, Kristin
Beitler, Jonathan J.
El-Deiry, Mark W.
Wadsworth, J. Trad
Hudgins, Patricia A.
Saba, Nabil F.
Schuster, David M. - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objective</title> <p>The aim of this study was to explore the relationship of PET/CT parameters with human papillomavirus (HPV) status of oropharyngeal (OP) and oral cavity (OC) squamous cell carcinomas (SCCs).</p> </sec> <sec> <title>Patients and Methods</title> <p>We retrospectively reviewed 39 patients with OC and OP-SCC who underwent staging <sup>18</sup>F-FDG PET/CT. PET/CT parameters were measured for the primary tumor and the hottest involved node, including SUV<sub>max</sub>, SUV<sub>mean</sub>, SUV<sub>peak</sub>, metabolic tumor volume, total lesion glycolysis, standardized added metabolic activity (SAM), and normalized SAM. Patient characteristics were compared between HPV positive (HPV+) and negative (HPV−) groups. Receiver operating characteristic analysis was used to dichotomize PET/CT parameters into high and low. Logistic regression models predicting HPV status were fit for each PET/CT parameter.</p> </sec> <sec> <title>Results</title> <p>The HPV+ group was composed of 18 patients all with OP-SCC; the HPV− group consisted of 21 patients, 4 OP cancer patients and 17 OC cancer patients. The HPV+ group had a higher proportion of N2 stage (94% vs 43%; <italic>P</italic> &lt; 0.001). Nodal PET/CT parameters were higher in the HPV+ group (<italic>P</italic> &lt; 0.01); this difference was not present for the primary lesion. After adjusting for sex and age, the association of higher nodal<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objective</title> <p>The aim of this study was to explore the relationship of PET/CT parameters with human papillomavirus (HPV) status of oropharyngeal (OP) and oral cavity (OC) squamous cell carcinomas (SCCs).</p> </sec> <sec> <title>Patients and Methods</title> <p>We retrospectively reviewed 39 patients with OC and OP-SCC who underwent staging <sup>18</sup>F-FDG PET/CT. PET/CT parameters were measured for the primary tumor and the hottest involved node, including SUV<sub>max</sub>, SUV<sub>mean</sub>, SUV<sub>peak</sub>, metabolic tumor volume, total lesion glycolysis, standardized added metabolic activity (SAM), and normalized SAM. Patient characteristics were compared between HPV positive (HPV+) and negative (HPV−) groups. Receiver operating characteristic analysis was used to dichotomize PET/CT parameters into high and low. Logistic regression models predicting HPV status were fit for each PET/CT parameter.</p> </sec> <sec> <title>Results</title> <p>The HPV+ group was composed of 18 patients all with OP-SCC; the HPV− group consisted of 21 patients, 4 OP cancer patients and 17 OC cancer patients. The HPV+ group had a higher proportion of N2 stage (94% vs 43%; <italic>P</italic> &lt; 0.001). Nodal PET/CT parameters were higher in the HPV+ group (<italic>P</italic> &lt; 0.01); this difference was not present for the primary lesion. After adjusting for sex and age, the association of higher nodal SUV<sub>max</sub> (odds ratio [OR], 9.67), SUV<sub>mean</sub> (OR, 10.48), SUV<sub>peak</sub> (OR 9.67), metabolic tumor volume (OR, 14.52), total lesion glycolysis (OR, 11.84), and SAM, normalized SAM (OR, 16.21) with HPV+ status remained statistically significant (<italic>P</italic> &lt; 0.05).</p> </sec> <sec> <title>Conclusions</title> <p>Nodal PET/CT parameters predict HPV status. High nodal FDG uptake should raise suspicion for positive HPV status in the evaluation of the primary lesion.</p> </sec> </abstract> … (more)
- Is Part Of:
- Clinical nuclear medicine. Volume 40:Number 3(2015)
- Journal:
- Clinical nuclear medicine
- Issue:
- Volume 40:Number 3(2015)
- Issue Display:
- Volume 40, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 40
- Issue:
- 3
- Issue Sort Value:
- 2015-0040-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-03
- Subjects:
- Nuclear medicine -- Periodicals
Radioisotope scanning -- Periodicals
Nuclear Medicine -- Periodicals
616.07575 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00003072-000000000-00000 ↗
http://journals.lww.com/nuclearmed/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/RLU.0000000000000691 ↗
- Languages:
- English
- ISSNs:
- 0363-9762
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.314000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4208.xml